Neobe Therapeutics

Neobe is a biotech company developing a bacteria-engineering platform to increase immunotherapy efficacy in non-responsive cancer patients through programmable live biotherapeutics. The platform is based on safe strains of commensal bacteria with tumour-colonizing properties. The bacteria are engineered to be activated within solid tumours to break down fibrotic barriers to immune infiltration without affecting healthy tissues, thereby enabling the efficacy of immunotherapy while avoiding off-target toxicity